MD, PhD, MBA
Dr. David Greene, MD, PhD, MBA, stands at the forefront of regenerative medicine and healthcare innovation, blending clinical expertise with entrepreneurial vision. As the founder and CEO of R3 Stem Cell and US Lead Network, Dr. Greene has dedicated his career to advancing patient care and empowering medical practices through advanced therapies and digital marketing excellence.
A residency and fellowship-trained orthopedic surgeon, Dr. Greene began his journey in medicine with a deep commitment to helping others. After years in clinical practice, he recognized the transformative potential of regenerative therapies and the urgent need for better patient access and education. This insight led him to establish R3 Stem Cell, now a global leader in non-surgical treatment options using stem cell and PRP therapy. Under his leadership, R3 Stem Cell has performed over 26,000 procedures across more than 45 international clinics, offering hope and healing to patients worldwide.
Dr. Greene’s entrepreneurial spirit didn’t stop at clinical innovation. He also founded US Lead Network, a healthcare internet marketing company that leverages artificial intelligence to help medical and dental practices grow their patient base efficiently and ethically. His two books on healthcare internet marketing have become essential reading for providers seeking to navigate the complexities of digital patient acquisition. Recognized as a Top 20 Expert Author by Ezines.com – ranking #15 out of over 470,000 authors and #1 in Pain Management – Dr. Greene’s thought leadership has shaped the way healthcare professionals connect with patients online.
A defining moment in Dr. Greene’s career was his decision to leave clinical practice and focus entirely on innovation and education. “I’ve never been a fan of just settling for the status quo. Innovation is a cornerstone of what makes America great,” he reflects. This philosophy has driven R3 Stem Cell’s mission to provide affordable, high-quality regenerative care and to demystify stem cell therapies through comprehensive training courses and educational content for both providers and patients.
Dr. Greene’s work has garnered international recognition, including a feature on the cover of Corporate Vision magazine, where his commitment to affordable, accessible regenerative therapies was spotlighted. His impact extends beyond business metrics – he is known for his compassionate approach, always prioritizing patient education and ethical practice.
Outside of his professional life, Dr. Greene is inspired by the words of Maya Angelou: “My mission in life is not merely to survive, but to thrive; and to do so with some passion, some compassion, some humor, and some style”. He brings this ethos to his daily work, fostering a culture of innovation, empathy, and continuous learning.
When he’s not leading global healthcare initiatives, Dr. Greene enjoys sharing insights on social media, connecting with colleagues, and pursuing personal interests that keep him grounded and inspired.
Dr. David Greene’s journey is a testament to the power of combining clinical skill, business acumen, and a heartfelt commitment to making a difference – one patient, one practice, and one innovation at a time.
All Posts
Peripheral neuropathy is a staggering global health issue, stemming from over 100 distinct causes. It is most prevalent among diabetics—affecting nearly 50% of that population—and cancer survivors, with upwards of 85% of chemotherapy patients experiencing some form of nerve damage. Other contributors include heavy metal
Erectile dysfunction (ED) is a deeply personal and often frustrating condition that impacts millions of men worldwide. While traditional treatments like oral medications and injections have long been the standard of care, they merely manage symptoms and can lose effectiveness over time. For patients seeking
When treating osteoarthritis and chronic joint degradation, patients often ask if they should choose Platelet-Rich Plasma (PRP) or Stem Cell Therapy. At R3 Stem Cell, especially in our Tijuana, Mexico clinic, our medical director Dr. Ivan—a prominent member of the Mexican Council of Stem Cell
When considering a life-changing procedure like umbilical cord stem cell therapy, it is natural to wonder about the long-term biological impact. A common question our experts at R3 Stem Cell receive is: “Will the donor’s DNA become part of my DNA?” Patients often worry about
In the world of regenerative medicine, achieving the highest cell count is often the primary goal for patients seeking relief from chronic conditions. However, there is a technical side to this process that patients rarely hear about: culturing. While culturing allows labs to expand a
When patients invest in regenerative medicine, one of the most pressing questions is: “Is this a one-and-done procedure, or will I need to come back?” Dr. David Green, Founder and CEO of R3 Stem Cell, addresses this with total candor. While everyone looks for the
When making a significant healthcare decision like undergoing regenerative medicine, patients naturally have deep questions about how these cells interact with their bodies. One of the most frequent questions our providers at R3 Stem Cell hear is: “Do the stem cells given to me become
When considering regenerative medicine, the most critical question a patient can ask is: “How do I know this tissue is safe?” At R3 Stem Cell, the world’s largest provider of regenerative cellular therapies, safety isn’t just a goal—it is our absolute baseline. Under the leadership
For many diagnosed with ataxia, the medical journey is often defined by a single, discouraging word: progressive. Whether it is an inherited condition or an acquired injury, the standard medical advice has long been that there is “no hope” for recovery and that patients must
Living with Type 2 Diabetes is a constant balancing act. When blood sugar remains uncontrolled, the high glucose levels act like a slow-moving toxin, damaging various organs across the body. The most devastating complication for many is Diabetic Nephropathy—or diabetic kidney failure. For years, the
